Skip to content

Primary or Secondary: The Lab Pattern That Decides Whether Enclomiphene Works

Published 10/21/2026

Contents

Key Takeaways

  • Low testosterone with high LH and FSH points to primary hypogonadism: the testes are not responding to a signal that is already strong.
  • Low testosterone with low or normal LH and FSH points to secondary hypogonadism, where the signal from the brain is the problem.
  • Symptoms are identical in both. Only bloodwork separates them.
  • Enclomiphene works by raising LH and FSH, so it has something to amplify only in secondary hypogonadism.
  • In a published comparison, 25 mg of enclomiphene raised LH from 5.3 to 11.9 mIU/mL and FSH from 9.4 to 14.9 mIU/mL.

Two men can walk in with the same complaint, the same symptoms, and nearly the same testosterone number, and need completely different conversations about treatment.

The thing that separates them is not on the part of the lab report most men read. It is two lines further down: LH and FSH.

The Same Problem, Two Different Places

Testosterone production runs on a chain of command. The hypothalamus signals the pituitary. The pituitary releases luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH tells the Leydig cells in the testes to make testosterone, and FSH supports sperm production.

A low testosterone result means something in that chain is failing. There are only two places it can fail.

Primary hypogonadism is a failure at the testes. The brain is sending the signal correctly, and sometimes shouting it, but the testes cannot respond.

Secondary hypogonadism is a failure of signalling. The testes are capable, but the instruction arriving from the pituitary is too weak.

Same number on the report. Same fatigue, same loss of drive, same difficulty holding muscle. Entirely different mechanism.

One draw, the whole picture. 136 biomarkers. Comprehensive Panel, $249, no insurance required. See what's in the panel.

How LH and FSH Tell Them Apart

This is the useful part, and it is simpler than it sounds.

When the testes stop responding, the brain does what any control system does when its instruction is ignored: it increases the signal. So in primary hypogonadism you see low testosterone alongside high LH and FSH. The pituitary is pushing harder and nothing is happening.

In secondary hypogonadism the problem is upstream, so there is no compensatory push. You see low testosterone alongside LH and FSH that are low, or sitting in the normal range when they should be elevated. A normal LH in the presence of genuinely low testosterone is itself an abnormal finding, because a functioning feedback loop would have raised it.

That is the whole test. High gonadotropins means the factory is broken. Low or inappropriately normal gonadotropins means the order never arrived.

What Causes Each

Primary traces to the testes themselves. Klinefelter syndrome, a genetic condition where a man is born with an extra X chromosome, is among the most common causes and affects roughly 1 in 500 to 1,000 newborn males, many undiagnosed until adulthood. Mumps orchitis, undescended testicles, physical trauma, chemotherapy or radiation, and iron overload from hemochromatosis can all damage testicular tissue enough to reduce production permanently.

Secondary traces to the hypothalamus or pituitary. Pituitary tumours, Kallmann syndrome, chronic illness, obesity, sleep apnoea, prolonged opioid use, and anabolic steroid use all interrupt signalling. Several of these are reversible, which matters: if opioid use or untreated sleep apnoea is suppressing the signal, addressing that can restore production without any hormone prescription at all.

Age sits across both. Testosterone production declines gradually in most men, and the pattern is often mixed rather than cleanly one or the other.

Why This Decides Treatment

Here is where the distinction stops being academic.

Enclomiphene works by increasing LH and FSH. It is a selective estrogen receptor modulator that blocks estrogen feedback at the hypothalamus and pituitary, which releases the brake on gonadotropin release. In a published pharmacodynamic study, men taking 25 mg of enclomiphene saw LH rise from 5.3 to 11.9 mIU/mL and FSH from 9.4 to 14.9 mIU/mL, with testosterone following.

Read that mechanism against the two patterns and the answer falls out.

In secondary hypogonadism, a weak signal is exactly the problem, and amplifying it is exactly the fix. The testes can respond; they just need a louder instruction.

In primary hypogonadism, LH and FSH are already elevated and the testes are already failing to answer. Raising a signal that is being ignored does not help. Enclomiphene is not effective for men with a diagnosis of primary hypogonadism, and no dose adjustment changes that, because the limitation is mechanical rather than a matter of strength.

This is also why the fertility difference exists. Because enclomiphene works through the body's own axis rather than replacing the hormone from outside, FSH rises alongside LH. In a comparison against transdermal testosterone, men on testosterone gel had no sperm concentrations above 12 million/mL at three months, while no man on enclomiphene fell below 75 million/mL, with a mean of 176 million/mL. Replacement suppresses the axis. Stimulation does not.

Getting the Right Panel

If you are being evaluated, the panel that answers this question includes:

  • Total testosterone, measured fasting in the morning, then repeated to confirm
  • LH and FSH, which is the part that classifies the problem
  • SHBG, without which free testosterone cannot be interpreted
  • Free or bioavailable testosterone, particularly where SHBG is likely abnormal
  • Prolactin, since an elevated level can point to a pituitary cause
  • Thyroid function and a complete blood count, to separate out conditions that mimic low testosterone

A panel that measures total testosterone alone can tell you that something is wrong. It cannot tell you where, and therefore cannot tell you what would help.

Testosterone, tailored to you. $79 labs plus a physician review. Check your T levels.

Frequently Asked Questions

What is the difference between primary and secondary hypogonadism?

Primary begins at the testes, which cannot respond to normal or elevated signalling. Secondary begins at the hypothalamus or pituitary, which does not send an adequate signal. The symptoms are the same; the bloodwork pattern differs.

Does high LH mean primary hypogonadism?

High LH and FSH alongside low testosterone is the characteristic pattern of primary hypogonadism. The brain is compensating for testes that are not responding. Interpretation still belongs with a clinician who has your full panel and history.

Can you have both primary and secondary hypogonadism?

Yes. Mixed pictures are common, particularly with age, and the gonadotropin pattern can be ambiguous. This is one reason classification is a clinical judgement rather than a calculation.

Is secondary hypogonadism reversible?

Sometimes. Where the cause is obesity, opioid use, untreated sleep apnoea, or prior anabolic steroid use, addressing the underlying factor can improve production. Genetic and structural causes generally require ongoing treatment.

Which type does enclomiphene treat?

Secondary only. It raises LH and FSH, so it requires testes able to respond to that increase. It is not effective in men diagnosed with primary hypogonadism.

The Bottom Line

Low testosterone is a result, not a diagnosis. The diagnosis is where in the chain it failed, and that question is answered by LH and FSH rather than by how you feel.

It is also the question that decides which treatments are even available to you, which is why a panel that skips the gonadotropins has left out the most consequential part.

Normal is a range. Yours is a number. 136 biomarkers, physician-reviewed. See what's in the panel.

Sources:

Enclomiphene citrate for the treatment of secondary male hypogonadism | National Library of Medicine

Testosterone restoration using enclomiphene citrate in men with secondary hypogonadism: a pharmacodynamic and pharmacokinetic study | National Library of Medicine

Treatment of hypogonadotropic male hypogonadism: case-based scenarios | National Library of Medicine

Male Hypogonadism | StatPearls, National Library of Medicine

Klinefelter Syndrome | Eunice Kennedy Shriver National Institute of Child Health and Human Development

Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline | Journal of Clinical Endocrinology & Metabolism